HIV-associated lymphomas

Current Opinion in Oncology

Volumn 9, Issue 5, 1997, Pages 450-454

  Straus, David J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; LOMUSTINE; METHOTREXATE; PREDNISONE; PROCARBAZINE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VINCRISTINE;

B LYMPHOCYTE; BONE MARROW SUPPRESSION; CANCER INCIDENCE; CLINICAL TRIAL; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; MAJOR CLINICAL STUDY; META ANALYSIS; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030823302     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199709050-00009     Document Type: Short Survey

References (46)

1. Ziegler JL, Beckstead JA, Volberding PA, et al.: Non-Hodgkin's lymphoma in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984, 11:565-570.
2. Kaplan LD, Abrams DI, Feigal E, et al.: AIDS-associated non-Hodgkin's lymphoma in San Francisco. J Am Med Assoc 1989, 261:719-724.
3. Knowles DM, Chamulak GA, Subar M, et al.: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): the New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 1988, 108:744-753.
4. Lowenthal DA, Straus DJ, Campbell SW, et al.: AIDS-related lymphoid neoplasia: the Memorial Hospital experience. Cancer 1988, 61:2325-2337.
5. Loureiro C, Gill PS, Meyer PR, et al.: Autopsy findings in AIDS-related lymphoma. Cancer 1988, 62:735-739.
6. Cesarman E, Chang Y, Moore PS, et al.: Kaposi's sarcoma-associated herpesvirus-like DNA in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332:1186-1191. Important description of a new entity and its association with a new human herpesvirus.
7. Nador RG, Cesarman E, Chadburn A, et al.: Primary effusion lymphoma: a distinct clinicopathologic entity associated with Kaposi's sarcoma-associated herpesvirus. Blood 1996, 88:645-656 Enlargement and update of original series of patients with this newly described entity.
8. Crane CA, Variakojis D, Rosen ST, et al.: Cutanous T-cell lymphoma in patients with human immunodeficiency virus infection. Arch Dermatol 1991, 127:989-994.
9. Goldstein J, Becker N, DelRowe J, et al.: Cutaneous T-cell lymphoma in a patient infected with human immunodeficiency virus type 1: use of radiation therapy. Cancer 1990, 66:1130-1132.
10. Lust JA, Banks PM, Hooper WC, et al.: T-cell non-Hodgkin's lymphoma in human immunodeficiency virus-1 -infected individuals. Am J Hematol 1989, 31:181-187.
11. Nahass GT, Kraffert CA, Penneys NS: Cutaneous T-cell lymphoma associated with the acquired immunodeficiency syndrome. Arch Dermatol 1991, 127:1020-1022.
12. Shaw MT, Jacobs SR: Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection. Cancer 1989, 64:2585-2587.
13. Chadburn A, Cesarman E, Jagirdar J, et al.: CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 1993, 72:3078-3090.
14. González-Clemente J, Ribera JM, Campo E, et al.: Ki-1+ anaplastic large-cell lymphoma of T-cell origin in an HIV-infected patient AIDS 1991, 5:751-755.
15. Herndier BG, Shiramizu BT, Jewett NE, et al.: Acquired immunodeficiency syndrome-associated T-cell lymphoma: evidence for human immunodeficiency virus type 1-associated T-cell transformation. Blood 1992, 79:1768-1774.
16. Tirelli U, Vaccher E, Zagonel V, et al. : CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol 1995, 13:373-380. Largest series of this recently described lymphoma in the setting of HIV infection.
17. Levine AM, Sullivan-Halley J, Pike MC, et al.: Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival. Cancer 1991, 68:2466-2472.
18. Gill PS, Levine AM, Krailo M, et al.: AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol 1987, 5:1322-1328.
19. Levine AM, Wernz JC, Kaplan L, et al.: Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. J Am Med Assoc 1991, 266:84-88.
20. Kaplan LD, Kahn JA, Crowe S, et al.: Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. J Clin Oncol 1991, 9:929-940.
21. Walsh C, Wernz JC, Levine A, et al.: Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma. J Acq Immune Defic Synd 1993, 6:265-271.
22. Kaplan LD, Straus D, Testa MA, et al.: Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus. N Eng J Med 1997, 336:1641-1648. Large randomized trial demonstrating the equivalence of results of low-dose with standard-dose chemotherapy for patients with HIV-associated non-Hodgkin's lymphomas.
23. Remick SC, McSharry JJ, Wolf BC, et al.: Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma. J Clin Oncol 1993, 11:1691-1702.
24. Sparano JA, Wiernik PH, Hu X, et al.: Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma. J Clin Oncol 1996, 14:3026-3035. Update of experience with infusional chemotherapy with the addition of ddl in two dosage schedules.
25. Warrell RP, Lee BJ, Kempin SJ, et al.: Effectiveness of methyl-GAG (Methylglyoxal-bis[Guanylhydrazonel]) in patients with advanced malignant lymphoma. Blood 1981, 57:1011-1014.
26. Levine AM, Tulpule A, Tessman D, et al.: Mitoguazone therapy inpatients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial. J Clin Oncol 1997, 15:1094-1103. Report of a drug previously shown to be active in NHL also to have activity in prior-treated patients with HIV-associated NHL with acceptable toxicity.
27. Vaccher E, Tirelli U, Soina M, et al.: Age and serum lactic dehydrogenase level are independently prognostic factors in human immunodeficiency virus-related on-Hodgkin's lymphomas: a single institute study of 96 patients. J Clin Oncol 1996, 14:2217-2223.
28. Straus D, Huang J, Testa M, et al.: Prognostic factors in the treatment of HIV-associated non-Hodgkin's lymphoma (HANHL): analysis of ACTG 142 (low-dose vs standard-dose mBACOD + GM-GCSF) [abstract]. Blood 1995, 86(suppl 1):604.
29. Gisselbrecht C, Oksenhendler E, Tirelli U, et al.: Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. Am J Med 1993, 95:188-196.
30. Straus DJ, Wong GY, Liu J, et al.: Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. Am J Med 1991, 90:328-337.
31. Mazza P, Bocchia M, Tumietto F, et al.: Recombinant interleukin-2 (rIL-2) in acquired immune deficiency syndrome (AIDS): preliminary report in patients with lymphoma associated with HIV infection. Eur J Haematol 1992, 49:1-6.
32. Bernstein ZP, Porter MM, Gould M, et al.: Prolonged administration of low-dose interleukin-2 human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. Blood 1995, 86:3287-3294. Phase I trial of low-dose IL-2 in patients with AIDS malignancies. This is the basis of subsequent trials with this agent in HIV-associated NHL.
33. Emilie D, Wijdenes J, Gisselbrecht C, et al: Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. Blood 1994, 84:2472-2479.
34. Baumgartner JE, Rachlin JR, Beckstead JH, et al.: Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990, 73:206-211.
35. Galetto G, Levine A: AIDS-associated primary central nervous system lymphoma. J Am Med Assoc 1993, 269:92-93.
36. Villringer K, Jäger H, Dichgans M, et al.: Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Computer Assisted Tomography 1995, 19:532-536.
37. Pierce MA, Johnson MD, Maciunas RJ, et al.: Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med 1995, 123:594-598. Important new technology that appears to help in the diagnosis of HIV-associated NHL of the CNS and obviate the need for diagnostic brain biopsy in all patients.
38. DeAngelis LD, Wong E, Rosenblum M, et al.: Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma. Cancer 1992, 70:1608-1611.
39. MacMahon EM, Glass JD, Hayward SD, et al.: Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991, 338:969-973.
40. Hamilton-Dutoit SJ, Raphael M, Audouin J, et al: In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 1993, 82:619-624.
41. Cinque P, Brytting M, Vago L, et al.: Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993, 342:398-401.
42. DeLuca A, Antinori A, Cingolani A, et al.: Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995, 90:844-849. Prospective study correlating these CSF markers with HIV-associated NHL of the CNS. Another means of possibly obviating the need for diagnostic brain biopsies in all patients.
43. Forsyth PA, Yahalom J, DeAngelis LM: Combined modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 1994, 44:1473-1479.
44. Chamberlain MC: Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma. Cancer 1994, 3:1728-1730.
45. Tirelli U, Errante D, Dolcetti R, et al.: Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995, 13:1758-1767. Largest series of HIV-associated Hodgkin's disease in the literature.
46. Rubio R: Hodgkin's disease associated with human immunodeficiency virus infection: a clinical study of 46 cases. Cancer 1994, 73:2400-2407.